SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward

The world awaits a SARS-CoV-2 virus (i.e., COVID-19 disease) vaccine to keep the populace healthy, fully reopen their economies, and return their social and healthcare systems to “normal.” Vaccine safety and efficacy requires meticulous testing and oversight; this paper describes how despite grandio...

Full description

Saved in:  
Bibliographic Details
Main Author: Iserson, Kenneth V. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Cambridge Univ. Press 2021
In: Cambridge quarterly of healthcare ethics
Year: 2021, Volume: 30, Issue: 1, Pages: 59-68
Further subjects:B Immunization
B Covid-19
B vaccines
B vaccine testing
B SARS-CoV-2 virus
Online Access: Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000naa a22000002 4500
001 1827978007
003 DE-627
005 20221220052649.0
007 cr uuu---uuuuu
008 221220s2021 xx |||||o 00| ||eng c
024 7 |a 10.1017/S096318012000047X  |2 doi 
035 |a (DE-627)1827978007 
035 |a (DE-599)KXP1827978007 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Iserson, Kenneth V.  |e VerfasserIn  |4 aut 
245 1 0 |a SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a The world awaits a SARS-CoV-2 virus (i.e., COVID-19 disease) vaccine to keep the populace healthy, fully reopen their economies, and return their social and healthcare systems to “normal.” Vaccine safety and efficacy requires meticulous testing and oversight; this paper describes how despite grandiose public statements, the current vaccine development, testing, and production methods may prove to be ethically dubious, medically dangerous, and socially volatile. The basic moral concern is the potential danger to the health of human test subjects and, eventually, many vaccine recipients. This is further complicated by economic and political pressures to reduce government oversight on rushed vaccine testing and production, nationalistic distribution goals, and failure to plan for the widespread immunization needed to produce global herd immunity. As this paper asserts, the public must be better informed to assess promises about the novel vaccines being produced and to tolerate delays and uncertainty. 
601 |a SARS-CoV-2 
601 |a COVID-19 
650 4 |a Immunization 
650 4 |a vaccine testing 
650 4 |a vaccines 
650 4 |a SARS-CoV-2 virus 
650 4 |a Covid-19 
773 0 8 |i Enthalten in  |t Cambridge quarterly of healthcare ethics  |d Cambridge : Cambridge Univ. Press, 1992  |g 30(2021), 1, Seite 59-68  |h Online-Ressource  |w (DE-627)306655039  |w (DE-600)1499985-7  |w (DE-576)081985010  |x 1469-2147  |7 nnns 
773 1 8 |g volume:30  |g year:2021  |g number:1  |g pages:59-68 
856 4 0 |u https://doi.org/10.1017/S096318012000047X  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/sarscov2-covid19-vaccine-development-and-production-an-ethical-way-forward/7A6A9FC206CD066689A44DEF52609729  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4235382918 
LOK |0 003 DE-627 
LOK |0 004 1827978007 
LOK |0 005 20221220052649 
LOK |0 008 221220||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-12-06#19DF6E6418D7E0B3352E32B7A5A29EBB582553EB 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw